Achieve Life Sciences Inc (ACHV)
4.735
-0.02
(-0.32%)
USD |
NASDAQ |
May 08, 10:59
Achieve Life Sciences Free Cash Flow: -24.50M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.50M |
| September 30, 2023 | -31.27M |
| June 30, 2023 | -37.43M |
| March 31, 2023 | -39.09M |
| December 31, 2022 | -37.57M |
| September 30, 2022 | -31.64M |
| June 30, 2022 | -29.03M |
| March 31, 2022 | -29.77M |
| December 31, 2021 | -29.44M |
| September 30, 2021 | -26.70M |
| June 30, 2021 | -22.35M |
| March 31, 2021 | -15.48M |
| December 31, 2020 | -13.49M |
| September 30, 2020 | -14.43M |
| June 30, 2020 | -13.16M |
| March 31, 2020 | -14.79M |
| December 31, 2019 | -15.27M |
| September 30, 2019 | -15.40M |
| June 30, 2019 | -15.31M |
| March 31, 2019 | -13.38M |
| December 31, 2018 | -10.67M |
| September 30, 2018 | -10.74M |
| June 30, 2018 | -13.22M |
| March 31, 2018 | -11.33M |
| December 31, 2017 | -9.107M |
| Date | Value |
|---|---|
| September 30, 2017 | 17.06M |
| June 30, 2017 | 15.24M |
| March 31, 2017 | 8.874M |
| December 31, 2016 | -0.202M |
| September 30, 2016 | -33.50M |
| June 30, 2016 | -34.90M |
| March 31, 2016 | -11.91M |
| December 31, 2015 | -9.472M |
| September 30, 2015 | -5.663M |
| June 30, 2015 | -2.768M |
| March 31, 2015 | -22.34M |
| December 31, 2014 | -17.39M |
| September 30, 2014 | -18.00M |
| June 30, 2014 | -22.47M |
| March 31, 2014 | -27.08M |
| December 31, 2013 | -36.18M |
| September 30, 2013 | -38.30M |
| June 30, 2013 | -41.02M |
| March 31, 2013 | -47.20M |
| December 31, 2012 | -43.78M |
| September 30, 2012 | -38.55M |
| June 30, 2012 | -31.79M |
| March 31, 2012 | -23.65M |
| December 31, 2011 | -20.34M |
| September 30, 2011 | -19.64M |
Free Cash Flow Range, Past 5 Years
-39.09M
Minimum
Mar 2023
-13.16M
Maximum
Jun 2020
-24.01M
Average
-24.50M
Median
Dec 2023
Free Cash Flow Benchmarks
| Accelerate Diagnostics Inc | -41.23M |
| Atossa Therapeutics Inc | -20.96M |
| ENDRA Life Sciences Inc | -9.583M |
| Perspective Therapeutics Inc | -37.98M |
| Electromed Inc | 3.653M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.364M |
| Cash from Investing (Quarterly) | -0.006M |
| Free Cash Flow Per Share (Quarterly) | -0.2063 |
| Free Cash Flow Yield | -26.11% |